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Abstract
A central challenge of synthetic biology is to enable the growth of living systems using parts that are not derived from
nature, but designed and synthesized in the laboratory. As an initial step toward achieving this goal, we probed the ability
of a collection of .10
6 de novo designed proteins to provide biological functions necessary to sustain cell growth. Our
collection of proteins was drawn from a combinatorial library of 102-residue sequences, designed by binary patterning of
polar and nonpolar residues to fold into stable 4-helix bundles. We probed the capacity of proteins from this library to
function in vivo by testing their abilities to rescue 27 different knockout strains of Escherichia coli, each deleted for a
conditionally essential gene. Four different strains – DserB, DgltA, DilvA, and Dfes – were rescued by specific sequences from
our library. Further experiments demonstrated that a strain simultaneously deleted for all four genes was rescued by co-
expression of four novel sequences. Thus, cells deleted for ,0.1% of the E. coli genome (and ,1% of the genes required for
growth under nutrient-poor conditions) can be sustained by sequences designed de novo.
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Introduction
In 1906 Jacques Loeb suggested that the synthesis of life is a
significant goal of biology [1]. A century later, the construction of
natural genomes from off-the-shelf chemicals [2,3] demonstrates
significant progress toward achieving this goal. Until now,
however, most advances in synthetic biology have relied on
collections of parts – genes, proteins, and regulatory elements –
derived from sequences that already exist in nature. Must the
toolkit of life be so restricted? Natural sequences comprise only a
miniscule fraction of the theoretical sequence space that is possible
for genes and proteins. Indeed, a collection containing just a single
molecule of every one of the 20
100 possible 100-residue proteins
would fill a volume larger than a mole of universes [4]. From this
enormous potential for diversity, natural selection has operated
over billions of years to yield a relatively small collection of
sequences: Life is sustained by only ,4,000 genes in E. coli and
approximately 5-fold more in humans [5,6]. These considerations
might lead to the supposition that genes and proteins capable of
sustaining life are somehow ‘‘special.’’ Is this true? Or might we
find functional molecular parts in a collection of artificial
sequences designed ‘‘from scratch’’ in the laboratory?
To address these questions, we probed the ability of unevolved
sequence space to encode functions that enable cell growth. We
designed and constructed a collection of artificial genes encoding
approximately 1.5610
6 novel amino acid sequences. Because
folding into a stable 3-dimensional structure is a prerequisite for
most biological functions, we did not construct this collection of
proteins from random sequences. Instead, we used the binary code
strategy for protein design, shown previously to facilitate the
production of large combinatorial libraries of folded proteins [7,8].
In brief, the binary code strategy posits that stably folded proteins
can be encoded by specifying the sequence pattern of polar and
nonpolar residues (the binary pattern) to coincide with the exposed
and buried parts of a structure, respectively. For example, to
design a helical bundle comprising a-helices with hydrophilic faces
exposed to aqueous solvent and hydrophobic faces buried in the
interior of a protein, the binary pattern of polar (P) and nonpolar
(N) residues should be PNPPNNPPNPPNNP, consistent with the
structural repeat of 3.6 residues per alpha-helical turn [9,10]. For
the current studies, we used the binary code strategy to design and
construct a library of sequences designed to fold into 102-residue
4-helix bundles. Our strategies for protein design and selecting
biological function are summarized in Figure 1. Details describing
the construction and biophysical characterization of the library are
presented elsewhere [11,12].
Here we demonstrate that novel proteins from this binary
patterned library can rescue E. coli cells that lack certain natural
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substantially less active, and may function by different mechanisms
than the natural proteins they replace. Nonetheless, co-expression
of several novel proteins rescues a strain in which multiple natural
genes were deleted simultaneously. These findings show that an
organism, which would otherwise not grow, can be sustained by
macromolecules devised in the laboratory.
Results and Discussion
De novo designed sequences rescue single-gene
knockout strains of E. coli
Previous work in our laboratory showed that several purified
proteins from our binary patterned alpha-helical libraries can bind
a cofactor and perform enzyme-like functions, including peroxi-
dase, lipase, and esterase activities [13]. These findings led us to
question whether proteins from this library might also provide
biological functions that enable cell growth. To address this
question, we tested the ability of binary patterned proteins to
rescue strains of E. coli in which a conditionally essential function
had been deleted. These strains were obtained from the Keio
collection, which contains all the viable single-gene knockout
strains of E. coli [5]. We tested 27 auxotrophs that grow on rich
media, but fail to grow on minimal media (see legend for Table 1).
Each auxotroph was transformed with a library of synthetic genes
carried on the expression vector pCA24NMAF2 [14]. Typically,
we obtained 5–10 million transformants, thereby ensuring
reasonably deep coverage of the library of 1.5610
6 de novo
sequences. As negative controls, each auxotroph was transformed
with the empty vector or the same vector expressing beta-
galactosidase. Transformed cells were spread either on LB (rich) or
on M9-glucose (minimal) media supplemented with isopropyl-
beta-D-thiogalactoside (IPTG) to induce expression, and the
formation of colonies was monitored (Figures 1 & 2).
On rich media, all transformed cells grew, regardless of whether
they received the control lacZ gene or a gene encoding a novel
protein. As expected, on minimal media, auxotrophs transformed
with the control plasmids failed to grow. (If the negative controls
grew, the strain was considered ‘leaky’ and not used for further
studies.) In most cases, auxotrophs transformed with the collection
of novel sequences also failed to produce colonies, even after weeks
of incubation. This indicates that proteins from the collection
could not rescue these strains. However, for four auxotrophs –
DserB, DgltA, DilvA, and Dfes – colonies formed on minimal plates
after several days of incubation (Figures 2A & 2B). Growth of these
cells under selective conditions suggests that a novel gene carried
by the plasmid complements the deletion. The rates of com-
plementation and the times required for colony formation are
summarized in Table 1.
To confirm that the colonies observed on selective media
resulted from the uptake of a novel gene and not from an adaptive
mutation on the chromosome, colonies were isolated by restreak-
ing, and plasmid DNA was purified; this DNA was then used to
transform naı ¨ve cells of the same auxotroph, and the transformed
cells were once again spread on both LB and minimal plates.
Growth of approximately the same number of colonies on selective
plates as on rich plates indicates that the observed phenotype
(growth on minimal) transferred with the genotype (the plasmid
carrying the novel gene). These results are shown in Figure 2C and
Figure S1. To ensure that rescue was due to a de novo protein, and
not some natural sequence that might have been picked up
inadvertently during plasmid constructions, we isolated the ,300
base pair fragment encoding the novel protein, recloned it into a
new vector, and showed that the new clone also rescued the
deletion strain.
The binary patterned sequences that rescue the four auxotrophs
are shown in Figure 3. (Additional sequences are shown in
Figure S2.) The novel sequences are designated according to the
Figure 1. Design of a collection of novel proteins and rescue of E. coli auxotrophs. Binary pattern of polar (red) and nonpolar (yellow)
residues designed to fold into 4-helix bundles (7, 8). Library construction is facilitated by the organization of the genetic code: Six polar residues (Lys,
His, Glu, Gln, Asp, and Asn) are encoded by the degenerate codon VAN, and five nonpolar residues (Met, Leu, Ile, Val, and Phe) are encoded by the
degenerate codon NTN. Combinatorial turn positions are encoded by the degenerate codon VRS, which encodes Gln, Glu, Asn, Asp, His, Lys, Arg, Ser,
and Gly. (V=A, G, or C; R=A or G; N=A, G, C, or T). Circles with letters indicate fixed residues, and empty circles indicate combinatorially diverse
positions. The theoretical diversity of this library is 5
2266
3468
12=5 610
52. The substantially smaller experimental library (1.5610
6 synthetic genes
cloned on a high expression plasmid) was transformed into a strain of E. coli in which an endogenous gene had been deleted (green X). Colony
formation on minimal media indicates a novel sequence (purple) enables cell growth under selective conditions.
doi:10.1371/journal.pone.0015364.g001
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synthetic sequence that rescues Dfes.) For the DgltA strain, we
isolated one novel protein that enabled cell growth. However, in
the other cases, several sequences were isolated, suggesting that
deletions of these genes are relatively easy to rescue. As shown by
the color-coding in Figure 3, the sequences of the biologically
active proteins conform to our binary pattern for the design of 4-
helix bundles. (As is often true for sequences in combinatorial
libraries, spurious mutations were observed occasionally, but these
do not interfere with the overall binary pattern – see Figure S2).
NCBI-BLAST searches indicate the sequences of the de novo
proteins are unlike those of any known natural proteins [15].
The ability of each de novo protein to sustain cell growth was
measured in cultures grown in minimal M9-glucose liquid media.
Growth rates were compared for deletion strains expressing a de
novo protein versus the same strains expressing either the negative
control (LacZ) or the corresponding natural protein on the same
pCA24NMAF2 vector. As shown in Figure 4, the novel proteins
enable cell growth under conditions where auxotrophs trans-
formed with the control plasmid fail to grow at all. Cells relying on
the de novo proteins grow significantly slower than those expressing
the natural protein. (Fes is an exception because overexpression of
E. coli Fes is toxic [14, Genobase ORF JW0576 - http://ecoli.
naist.jp/GB6/info.jsp?id=JW0576].) It is not surprising that the
unevolved novel sequences function at substantially lower levels
than natural sequences selected by billions of years of evolution.
Indeed, the relatively slow rates of cell growth enabled by these
first-generation de novo sequences suggest that selections for faster
growth might facilitate the evolution of more active proteins. Such
experiments will provide an opportunity to test whether de novo
progenitor sequences might lead to novel evolutionary trajectories.
The results shown in Figures 2 and 4 demonstrate that the de
novo sequences enable cell growth; however, viability per se does not
indicate that the novel proteins provide the same biochemical
activities as the deleted natural proteins. Therefore, we devised a
series of experiments to probe the functions of the de novo proteins.
Biological functions of the de novo proteins
The natural genes deleted in these four auxotrophs encode a
range of functions (9). These are summarized below and depicted
graphically in Figure S3.
N serB encodes phosphoserine phosphatase, responsible for the
final step in serine biosynthesis:
phosphoserine R serine + phosphate.
N gltA encodes citrate synthase, which catalyzes an early step in
glutamate biosynthesis:
oxaloacetate + acetyl-coA R citrate R cis-aconitate R
isocitrate R alpha-ketoglutarate R glutamate.
N ilvA encodes biosynthetic threonine deaminase, which catalyzes
the first step in the production of isoleucine from threonine:
threonine R 2-ketobutyrate + ammonia RRRisoleucine.
N fes encodes enterobactin esterase, which cleaves the iron-bound
enterobactin siderophore, thereby enabling cells to acquire
iron in iron-limited environments [16].
In principle, the novel proteins could rescue these auxo-
trophs either by providing the same function as the deleted
enzyme, or by one of the three alternative mechanisms
described below:
First, we considered the possibility that an auxotroph in a
biosynthetic pathway might be rescued by a de novo sequence that
produces the end product via a novel bypass pathway. Although
it seems unlikely that small, unevolved proteins could catalyze
Figure 2. Rescue of E. coli auxotrophs by de novo proteins. (A) E. coli strain BW25113 Dfes was transformed with a control plasmid
overexpressing LacZ (left half), or with a library of plasmids encoding the collection of novel proteins (right half). Cells were plated on M9-glucose
supplemented with 50 mM IPTG, 30 mgm l
21 kanamycin, and 34 mgm l
-1 chloramphenicol. Cells transformed with the control plasmid fail to grow,
whereas cells transformed with the library yield occasional colonies. (B) Similar results for DilvA. (Similar results were also observed for DserB and
DgltA – data not shown.) (C) Re-transformation of DilvA cells with a single sequence, syn-ilvA-1. A similar number of colonies grow on M9-glucose
(left) as on LB (right). Results for other sequences were similar to those shown in (C), and are summarized in Figure S1.
doi:10.1371/journal.pone.0015364.g002
Table 1. Complementation frequency and time required for
colony formation on selective media (M9-glucose).
Complementation
Frequency
Time to
Grow (Days)
DserB ,1/50,000 4
DgltA ,1/1,000,000 4
DilvA ,1/3,000 3
Dfes ,1/10,000 2
Novel proteins capable of enabling cell growth were isolated for 4 strains.
Complementation frequency was calculated by dividing the number of colonies
on selective plates (rescued transformants) by the number of colonies on rich
plates (total transformants). This apparent frequency was then adjusted to
estimate the true complementation rate by correcting for any false positives
that failed to restreak or retransform. The following additional strains from the
Keio collection were tested, but were not rescued by sequences from the
library: DargB, DargE, DargH, DaroB, DaroC, DaroD, DaroE, DbioA, DcysG, DglnA,
DhisA, DilvC, DilvD, DleuB, DleuC, DleuD, DpdxA, Dppc, DproB, DpurF, DpyrF,
DthrB,a n dDthrC.
doi:10.1371/journal.pone.0015364.t001
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ity. If the novel sequences that rescue DserB, DgltA or DilvA
encode bypass pathways for the synthesis of serine, glutamate,
and isoleucine, respectively, then these de novo sequences would
also rescue cells deleted for enzymes that function at other
steps in the these biosynthetic pathways. (Pathways are shown in
Figure S3). This possibility was tested by the following three
experiments:
Figure 3. Designed amino acid sequences that enable growth of E. coli auxotrophs on selective media. Names of the novel (Syn)
proteins and the auxotroph rescued are listed at left. The novel sequences follow the designed binary pattern of polar (red) and nonpolar (yellow)
residues. The top line shows the template designed to encode four amphiphilic alpha-helices. Combinatorial positions are shown as empty circles
(polar residues), filled circles (nonpolar residues), or hyphens (turn residues). Sequences were submitted to the European Nucleotide Archive and
assigned accession numbers FR718891 - FR718908.
doi:10.1371/journal.pone.0015364.g003
Figure 4. Growth of auxotrophic strains of E. coli in selective liquid media. In each panel, the bottom curve shows that the negative control
expressing LacZ (open circles) does not support growth. In contrast, most of the positive controls (black circles) expressing the natural E. coli proteins
grow well. (Fes is an exception because overexpression of E. coli Fes is toxic.) The designed proteins enable growth that is well above background. (A)
DserB: LacZ, open circles; SerB, closed circles; Syn-SerB-1, closed triangles; Syn-SerB-2, open triangles; Syn-SerB-3, closed squares; and Syn-SerB-4,
open squares. (B) DgltA: LacZ, open circles; GltA, closed circles; and Syn-GltA-1, closed triangles. (C) DilvA: LacZ, open circles; IlvA, closed circles; Syn-
IlvA-1, closed triangles; and Syn-IlvA-2, open triangles. (D) Dfes: LacZ, open circles; Fes, closed circles; Syn-Fes-1, closed triangles; Syn-Fes-2, open
triangles; Syn-Fes-3, closed squares; Syn-Fes-4, open squares; Syn-Fes-5, closed diamonds; Syn-Fes-6, open diamonds; Syn-Fes-7,6; and Syn-Fes-8, +.
doi:10.1371/journal.pone.0015364.g004
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DserC cells, which are deleted for phosphoserine aminotrans-
ferase. This enzyme converts phosphohydroxypyruvate to
phosphoserine in the step prior to that catalyzed by the serB
encoded enzyme. (Because the serC gene product is also
involved in the biosynthesis of pyridoxine [9], the selective
media for this experiment was supplemented with pyridoxine.)
(b) The sequence that rescued DgltA was transformed into Dicd
cells. This strain is also a glutamate auxotroph because it
cannot catalyze the conversion of isocitrate to alpha-
ketoglutarate, the direct precursor of glutamate.
(c) The sequences that rescued DilvA were transformed into
DilvC and DilvD cells, which are deleted for isomeroreductase
and dihydroxyacid dehydratase, respectively. Both these
enzymes function downstream of ilvA in the biosynthesis of
isoleucine. (Because the ilvC and ilvD gene products are also
involved in valine biosynthesis [9], the selective media for
these experiments was supplemented with valine.)
In all cases, the de novo sequences did not rescue E. coli cells
deleted for functions at other steps in the biosynthetic pathways.
This demonstrates that the novel proteins do not enable bypass
pathways for the synthesis of their respective end products.
Second, we considered the possibility that our de novo sequences
might rescue the auxotrophs by altering the expression or activity
of an endogenous E. coli protein. To assess this possibility, we
relied on an exhaustive screen by Patrick et al., who identified
natural genes whose overexpression can rescue the deletion of
noncognate genes in E. coli (i.e. ‘multicopy suppressors’) [17]. By
screening the complete set of overexpressed E. coli ORFs, they
found the following multicopy suppressors of our four strains: DilvA
can be rescued by overexpression of tdcB [18], or emrD; DserB can
be rescued by overexpression of gph, hisB, or ytjC; and Dfes can be
rescued by overexpression of thiL or setB. DgltA was not rescued by
overexpression of any E. coli genes. To probe whether our novel
sequences rely on these E. coli proteins for rescue, we tested
whether our proteins rescue the following double deletion strains:
DilvADtdcB, DilvADemrD, DserBDgph, DserBDytjC, and DfesDsetB.
Transformation with the appropriate novel sequences showed that
all five of these double knockouts were rescued by all of the
corresponding artificial sequences listed in Figure 3. The ability of
our novel sequences to rescue these double deletions shows that
the artificial proteins do not function by altering the expression or
activity of E. coli proteins known previously to enable rescue.
The double mutant DfesDthiL cannot be constructed because
deletion of thiL is lethal. The DserBDhisB strain was constructed,
but since DhisB is itself an auxotroph, our novel sequences did not
rescue this strain (successful rescue would require the unlikely
occurrence of a single de novo protein replacing the activities of two
conditionally essential genes.) Therefore, dependence on thiL and
hisB could not be assessed. In addition, it remains possible that
some other E. coli protein, which escaped selection by Patrick et al.,
could act as a partner in the rescue mediated by our de novo
sequences. With the exception of these caveats, our results
demonstrate that the known multicopy suppressors are not
required for the biological activities of our de novo proteins.
Third, we considered the possibility that the de novo proteins
might rescue the deletion strains by a mechanism that does not
depend on the specific sequences (Figure 3), but instead involves
global alterations in metabolism that are induced by the mere
expression of foreign genes. For example, although our proteins
were designed to fold into alpha-helical bundles, we considered the
possibility that sequences isolated by our selections might be
unfolded, and thereby induce a cellular stress response. To assess
folding, we purified several proteins and measured their circular
dichroism spectra. These spectra (shown in Figure S4) demonstrate
the structures are predominantly alpha-helical, and similar to the
spectra of designed 4-helix bundles solved previously by NMR
[19,20]. Thus, rescue is not caused by unfolded sequences
inducing a stress response.
We also note that if a generic stress response were responsible
for rescue, one would expect all the Syn proteins to rescue all the
deletions. This is not the case. Syn-Fes does not rescue DgltA, Syn-
SerB does not rescue DilvA, and so on. Thus, specific de novo
sequences mediate the rescue of specific chromosomal deletions.
To demonstrate explicitly that rescue depends on a specific
sequence, rather than a generic cellular response to the expression
of foreign genes, we mutated one of the de novo proteins. The
design of this mutant was based on an analysis of the common
features among the de novo sequences that rescued DilvA. Alignment
of the Syn-IlvA sequences revealed two conserved polar residues:
Glu36 and Lys42. We constructed the Lys42»Ala mutation in Syn-
IlvA-1, and found that although this protein was expressed at the
same level as the parental sequence, it fails to rescue DilvA. (These
results are shown in Figure S5) Thus, rescue is not simply due to
expression of an exogenous gene; it is mediated by sequence-
specific features of Syn-IlvA-1.
Fes differs from the other deletions because it is not involved in
a biosynthetic pathway. Fes functions in iron acquisition. E. coli
secretes the enterobactin siderophore (MW, 670 Da) into the
media, where it binds iron, and is transported back into the cell.
Because the affinity of enterobactin for iron is extremely high
(KD<10
235 M), release of the metal requires degradation of the
siderophore. This is catalyzed by the Fes protein, enterobactin
esterase [16]. The impact of the de novo syn-fes sequences on iron
acquisition is dramatic: Elemental analysis shows that cells
expressing the Syn-Fes proteins accumulate 6- to 10-fold more
iron than control cells (Figure S6). In principle, the de novo proteins
could rescue Dfes either by functioning as an esterase or by some
alternative mechanism. For example, the de novo proteins could
enable iron acquisition by being transported into the media,
binding iron with high affinity, being re-transported back into the
cell, and then releasing the tightly bound iron intracellularly.
Although possible, this alternative mechanism seems unlikely
for novel proteins that occur so frequently in a semi-random
library.
Irrespective of whether the de novo proteins rescue auxotrophs by
providing the same function as the deleted enzyme or by some
alternative mechanism, we expected the artificial sequences –
which were neither selected by evolution (in vivo or in vitro), nor
explicitly designed for enzymatic activity – to have far lower levels
of activity than naturally evolved sequences. To estimate this level
of activity in vivo, we compared the growth rates of deletion strains
expressing a high level (400X) of Syn-IlvA-1 to the same strain
expressing a low level (1X) of the natural protein, encoded by IlvA.
These experiments showed that even when the de novo protein is
expressed at ,400-fold higher levels than the natural protein, cells
grow much more slowly. (Growth rates are shown in Figure S7.)
As expected, the de novo protein exhibits a very low level of
biological activity.
Activity levels that are barely sufficient to sustain slow cell
growth may not be detectable in vitro. Indeed, others have reported
that although overexpression of one E. coli protein can sometimes
rescue the deletion of another protein in vivo, these ‘moonlighting’
activities can be so low that they cannot be detected in vitro [21,22].
Despite these concerns, we attempted to assay biochemical
activities in vitro using both cell lysates and purified proteins.
Lysates are easy to prepare and are more likely to contain
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The disadvantage of lysates, however, is that background activities
may obscure the low-level activities of the de novo proteins. We
assayed for phosphoserine phosphatase, enterobactin esterase,
threonine deaminase, and citrate synthase activities in lysates from
cells expressing the respective de novo proteins. In several cases,
activity was observed, however, lysates from control cells also
showed low levels of activity. This was not surprising, particularly
for the Fes and SerB activities, since previous work in our
laboratory showed that E. coli lysates contain nonspecific esterases
and phosphatases [13].
We also purified several of the de novo proteins. (To avoid
contamination by the natural enzyme, purifications were from
strains deleted for the natural gene.) We tested these purified
proteins for the enzymatic activities deleted in the respective
auxotrophs, but were unable to detect activity that was reproduc-
ibly above the controls. There are several reasons why such
experiments might not demonstrate activity: (i) As noted above, the
novel proteins have extremely low levels of activity. (ii) The de novo
proteins may require cofactors. We do not know which cofactors
might be required, as the novel proteins may use different cofactors
than the natural enzymes. (iii) The novel proteins may function by
partnering with an E. coli protein. For example, the specificity of an
endogenous hydrolase might be altered by binding one of our
helical bundles. If this were the case, activity would not be observed
in preparations containing only the purified de novo protein. (iv) The
Syn protein may function by a different mechanism than the
deleted protein, and novel activities would not be detected in
experiments designed to assay the natural enzyme.
While we do not yet know the precise mechanisms by which the
novel proteins rescue these four deletions in E. coli, we have ruled
out several alternative mechanisms including (i) bypass pathways,
(ii) activation of known endogenous suppressors, and (iii) induction
of a generic stress response (see above). The slow growth rates of
cells relying on the novel proteins for survival indicate that
regardless of the actual mechanism, the de novo proteins have very
low levels of activity — as expected for sequences that were neither
designed nor evolved for function. Irrespective of whether the de
novo proteins catalyze the same biochemical reaction as the deleted
natural protein, or function by some alternative mechanism (and
whether they act directly or through interactions with endogenous
proteins), elucidating the molecular basis of auxotroph rescue will
enhance our understanding of the minimal functions necessary for
cell growth.
Replacement of 0.1% of the E. coli genome
We showed above that artificial genes enable cell viability.
Next, to assess whether portions of a genome can be replaced by
genetic information devised in the laboratory, we probed the
ability of several novel sequences to rescue the deletion of several
genes simultaneously. A quadruple knockout strain – Dfes DgltA
DilvA DserB – was constructed and designated QUAD. This strain
has severe growth defects: While the parent strain forms colonies
after overnight incubation on either nutrient-rich or nutrient-
poor media, QUAD requires almost two days to form colonies on
rich media, and as expected, does not form colonies on minimal
media. To assess the ability of artificial genes to substitute
simultaneously for the deleted functions, we transformed QUAD
with derivatives of the pQLinkN vector [23] co-expressing four
artificial genes shown above to rescue the four single-gene
knockouts. The sequences used for this experiment were syn-fes-2,
syn-gltA-1, syn-ilvA-1,a n dsyn-serB-2 (Figure 3). Transformed cells
were plated on minimal media. As a control, we transformed
QUAD with empty vector; no colonies were observed for the
control. However, as shown in Figure 5, transformation with the
vector expressing all four artificial genes produced colonies. As
discussed above, the individual Syn proteins are considerably less
active than the deleted natural proteins. Therefore, it is not
surprising that the simultaneous rescue of four deletions by four
artificial proteins produced small colonies that required 13 days
to appear. Nonetheless, the rescue of QUAD demonstrates that
novel sequences bearing no similarity to naturally evolved
proteins can compensate for deletion of a portion of the E. coli
chromosome.
The E. coli genome contains approximately 4,000 genes [5]. Of
these, only 290 are essential for survival under all conditions [24].
An additional 107 are required for growth in the nutrient-poor
media provided by M9 salts with glucose [17]. Thus, only ,400
genes are essential for growth in minimal media. Our results
demonstrate that at least 1% of the E. coli genome that is
absolutely required for growth under minimal conditions – and
0.1% of the entire E. coli genome – can be replaced by artificial
genes designed de novo.
Conclusion
We have demonstrated that sequences designed de novo can
provide functions necessary to sustain the growth of living cells. It
should be emphasized that these macromolecules were isolated
with relatively high frequency from a collection of sequences that
were designed to adopt a stable globular fold [7,8,19,20,25], but
were not explicitly designed for function.
Both in terms of linear sequence and 3-dimensional structure,
the novel proteins differ substantially from the natural proteins
they replace: The binary patterned sequences in Figure 3 show no
significant sequence similarity to any known proteins. At the
structural level, the 102-residue 4-helix bundles specified by our
design are much smaller and simpler than the structures of the four
natural proteins deleted in the auxotrophs. (Structures are shown
in Figure S8). Thus, although natural proteomes include diverse
structures and topologies, our studies show that in some cases, cell
growth can be sustained by much simpler structures.
The field of synthetic biology — and the related field of
astrobiology — aim to go beyond questions about ‘‘what already
exists’’ and attempt to probe ‘‘what might be possible?’’ The
results described here suggest that the toolkit for synthetic biology
need not be limited to genes and proteins that already exist in
nature. We tested 27 deletion strains using a library of 1.5 million
sequences designed to fold into 4-helix bundles. From these, we
found 18 artificial sequences (Figure 3 and Figure S2) that
compensate for the deletion of 4 different genes, and provide
biological functions enabling cell growth. Extension of this work to
other deletion strains, using larger libraries, and designs that
encode a greater diversity of protein structures can be expected to
increase substantially the number of life-supporting functions that
can be provided by genes designed de novo. The results described
here showing that sequences designed in the laboratory can
replace portions of the E. coli genome can therefore be viewed as
an initial step toward the construction of artificial genomes.
Materials and Methods
Construction of a library of de novo sequences
The design, construction, and characterization of a library of
artificial genes encoding binary-patterned de novo proteins are
reported elsewhere [11,12]. The library of gene inserts was
digested with NdeI and BsrGI, as was plasmid pCA24NMAF2.
Double-digested plasmid backbone was gel purified, and the
library insert and vector backbone were ligated. Ligation products
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PLoS ONE | www.plosone.org 6 January 2011 | Volume 6 | Issue 1 | e15364were transformed into electrocompetent XL1-blue (Stratagene) or
MDS42recA (Scarab Genomics, LLC). Colonies were harvested
by scraping from LB plates supplemented with 34 mgm l
-1
chloramphenicol (cam), and plasmid DNA was purified from the
resulting cell suspension. Aliquots from this library of plasmids
were used to transform the auxotrophs. The size of this library—
approximately 1.5610
6 different sequences—was estimated by
plating serial dilutions of the transformations of the initial ligation
products on LB-cam [12].
Isolation of de novo sequences that rescue auxotrophs
The collection of plasmids encoding our library of novel
sequences, and two negative control plasmids, pCA24N-lacZ and
pCA24NMAF2 (empty vector), were used to transform 27 E. coli
auxotrophs. These were chosen from Keio strains that grow on
LB, but not on M9-glucose. Following electroporation, cells were
outgrown at 37uC, harvested by centrifugation, washed and
resuspended in chilled M9 salts, and spread on both LB
supplemented with 30 mgm l
21 kanamycin (kan), 34 mgm l
21
cam; and on M9-glucose supplemented with 50 mM IPTG, 30 mg
ml
21 kan, 34 mgm l
21 cam. After several days at 33uC, plates were
scored for number of colonies. In addition, a 1:100 dilution of
library-transformed cells was spread onto LB-cam plates to
measure transformation frequency under conditions that were
non-selective for auxotroph growth.
Growth assays
Single colonies were inoculated into LB (30 mgm l
21 kan,
170 mgm l
21 cam). Following overnight growth at 37uC, 1 ml of
each culture was harvested by centrifugation at 4uC. Cell pellets
were washed and resuspended in 1 ml chilled M9 salts, and the
resulting cell suspensions were diluted 100-fold into M9-glucose
(50 mM IPTG, 30 mgm l
21 kan, 34 mgm l
21 cam). Cultures were
grown at 33uC and assayed by measuring absorbance at 600 nm.
Additional methods are described in Supporting Information
Text S1.
Supporting Information
Text S1 Supplementary materials and methods.
(DOC)
Figure S1 Reconfirmation of hits. Colony counts for re-
transformation of DilvA cells with several different hits. The
histogram summarizes 13 experiments of the type shown in
figure 2C. The number of colonies on M9-glucose minimal media
(dark blue) is similar to the number on LB rich media (light blue).
(TIFF)
Figure S2 De novo sequences with spurious mutations and
corresponding DilvA growth curves. (A) Novel sequences with
spurious mutations. Red indicates polar residues, yellow indicates
nonpolar residues, and turns are in blue. Syn-IlvA-3 and Syn-IlvA-
4 are 105-residue proteins differing by a single residue at position
28. Both exhibit a 4 amino acid insertion into helix 1, and a 1
amino acid deletion from helix 4. Syn-IlvA-5 is a 106-residue
protein, with an 11 amino acid insertion into the second helix and
a 7 amino acid deletion from helix 4. These spurious mutations
occur at the DNA level and are due either to errors in
oligonucleotide synthesis or rare instances of the mis-assembly of
library insert building blocks. As long as such spurious mutations
do not affect frame or introduce stop codons, the mutated
segments survive preselection, and as shown by our results, can
contribute to the synthesis of productive sequences. (B) Growth
curves for the DilvA strain expressing designed artificial proteins
with spurious mutations. The bottom curve shows that the
negative control expressing LacZ (open circles) does not enable
growth. In contrast, the positive control expressing IlvA (closed
circles) grows well. Like the novel sequences that adhere precisely
to the design, the designed proteins with spurious mutations enable
growth that is well above background. Growth curves correspond
to the sequences in A as follows: Syn-IlvA-3, closed squares; Syn-
IlvA-4, open squares; and Syn-IlvA-5, closed diamonds.
(TIFF)
Figure S3 Reactions and pathways of the deleted proteins. (A)
serB encodes phosphoserine phosphatase, responsible for the final
step in serine biosynthesis. (B) ilvA encodes biosynthetic threonine
deaminase, which catalyzes the first step in the production of
isoleucine from threonine. (C) fes encodes enterobactin esterase,
which cleaves iron-bound enterobactin. (D) gltA encodes citrate
synthase, which catalyzes an early step in glutamate biosynthesis.
(TIFF)
Figure 5. Rescue of a quadruple knockout E. coli by co-expression of 4 de novo proteins. (A) Schematic of knockout rescue. Top: Wild-type
E. coli transformed with empty vector forms colonies on M9/glucose minimal media. Middle: QUAD E. coli transformed with empty vector does not
form colonies on minimal media. Bottom: QUAD transformed with a vector co-expressing four de novo sequences forms colonies on minimal media.
(B) Colonies are not observed when QUAD is transformed with empty vector (top panel), but are observed when transformed with a vector
expressing four artificial genes (bottom panel). Scale bar=1 mm.
doi:10.1371/journal.pone.0015364.g005
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that purified de novo proteins fold into alpha-helical structures.
Cultures of E. coli were grown to an OD600 of approximately 0.6
and induced with IPTG. Protein was extracted from the cells by
repeated cycles of freezing and thawing. Purification of the Syn
proteins to 95% (coommaise-stained SDS-PAGE) was achieved by
cation exchange chromatography. Proteins were dialyzed into
phosphate buffer for CD analysis.
(TIFF)
Figure S5 Mutation of Lys42 to Ala destroys the ability of a
synthetic protein to rescue DilvA. (A) Sequence alignment of the six
synthetic proteins that rescue DilvA. Two charged residues are
conserved, E and K (red arrows). Green lines mark regions that
are conserved in the designed template. (B) Transformation of
DilvA cells with Syn-IlvA-1 and Syn-IlvA-1-K42A. Cells expressing
Syn-IlvA-1 grow on M9-glucose, but cells expressing Syn-IlvA-1-
K42A do not. (C) SDS-PAGE of protein levels after induction with
IPTG. Levels of Syn-IlvA-1-K42A are approximately equivalent
to those of Syn-IlvA-1. Red arrow marks the band corresponding
to the synthetic protein.
(TIFF)
Figure S6 Assay for iron using inductively coupled plasma (ICP)
spectrometry. The Dfes strain was transformed with a plasmid
directing the high level expression of either LacZ or one of the
artificial sequences that rescued the fes deletion. Cells were grown
in LB, harvested, and tested for iron accumulation. The artificial
proteins enable the accumulation of 6-10 fold more iron than the
control.
(TIFF)
Figure S7 De novo proteins are considerably less active than the
natural proteins they replace. (A) Growth on minimal media of
DilvA cells expressing different sequences. Cells expressing the
natural IlvA protein grow well either in the presence (Blue) or
absence (Red) of IPTG. In contrast, cells expressing Syn-IlvA-1
grow significantly more slowly, even in the presence of IPTG
(Green). [These cells do not grow in the absence of IPTG.]
Control cells expressing LacZ fail to grow even in the presence of
IPTG (Purple). All proteins were expressed off the pCA24N
plasmid. (All curves except the red curve represent experiments
done in the presence of 0.5 mM IPTG.) (B) Beta-galactosidase
assays demonstrate that IPTG induces 402 (+/27) fold increase in
protein expression. LacZ was expressed from the pCA24N
plasmid, either in the presence or the absence of IPTG, and
levels of beta-galactosidase (Y-axis) were assayed according to
standard procedures. The data summarized in this figure show
that the Syn-IlvA protein is substantially less active than natural
IlvA. The beta-galactosidase assays in panel B demonstrate that
IPTG causes a 402 (+/27) fold increase in protein expression. The
results shown in panel A show that for the natural IlvA protein,
this change in expression level has no effect on the rate of cell
growth: Even low level expression in the absence of IPTG is
sufficient for the natural protein to sustain robust growth. In
contrast, cells that depend on Syn-IlvA grow slowly even when
expression is induced 400-fold. Since cells relying on 400x levels of
Syn-IlvA require significantly more time to grow than cells
expressing 1x levels of the natural protein, the artificial protein is
,1/400 as active as the natural protein. These experiments
demonstrate that the artificial proteins are substantially less active
in their ability to sustain cell growth. However, they do not
indicate that the artificial proteins function by the same
mechanism as the natural protein. Indeed, the reduced ability of
the artificial proteins to sustain cell growth may be due to their
functioning by a less effective mechanism.
(TIFF)
Figure S8 Structures of the 4 natural proteins compared with
protein S-824, a de novo 4-helix bundle from a binary patterned
library. Coordinates are from the PDB. (A) M. jannaschii SerB
(1f5s). (B) E. coli GltA (1k3p). (C) The asymmetric unit of E. coli
IlvA (1tdj). (D) S. flexneri Fes (3c87). (E) De novo protein S-824
(1p68).
(TIFF)
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